UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023016
Receipt number R000026528
Scientific Title Effect of treatment using moisturizing gel with different antimicrobials for dry mouth in palliative medicine
Date of disclosure of the study information 2016/07/22
Last modified on 2017/06/07 09:59:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of treatment using moisturizing gel with different antimicrobials for dry mouth in palliative medicine

Acronym

Oral-moisturizing gel for palliative medicine

Scientific Title

Effect of treatment using moisturizing gel with different antimicrobials for dry mouth in palliative medicine

Scientific Title:Acronym

Oral-moisturizing gel for palliative medicine

Region

Japan


Condition

Condition

Head and neck cancer

Classification by specialty

Oral surgery Dental medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate microbiological effect of oral moisturizing gel containing antimicrobial derived from food

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Microbes in saliva

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

5

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

250 ug/ml Propolis

Interventions/Control_2

30 ug/ml Curry leaf

Interventions/Control_3

62.5 ug/ml Turmeric

Interventions/Control_4

Placebo

Interventions/Control_5

0.05% Glucuronic chlorhexidine

Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Head and neck cancer patients
who has already received irradiation therapy at not less than 50 Gy.

Key exclusion criteria

Experience of any antibiotics usage within 3 mounths

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryoma Nakao

Organization

National Institute of Infectious Diseases

Division name

Department of Bacteriology I

Zip code


Address

1-23-1, Toyama, Shinjuku, Tokyo, Japan

TEL

+81-3-5285-1111

Email

ryoma73@nih.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryoma Nakao

Organization

National Institute of Infectious Diseases

Division name

Department of Bacteriology I

Zip code


Address

1-23-1, Toyama, Shinjuku, Tokyo, Japan

TEL

+81-3-5285-1111

Homepage URL


Email

ryoma73@nih.go.jp


Sponsor or person

Institute

National Institute of Infectious Diseases

Institute

Department

Personal name



Funding Source

Organization

Yamada Research Foundation
Sasakawa Foundation
Urakami Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 10 Month 11 Day

Last follow-up date

2017 Year 02 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 04 Day

Last modified on

2017 Year 06 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026528


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name